Dapagliflozin Medications

Dapagliflozin Info

Understanding Dapagliflozin

Dapagliflozin belongs to the class of medicines known as SGLT2 inhibitors. It helps the body get rid of excess sugar through the urine. In Hong Kong, dapagliflozin is most widely recognised as the active ingredient in the brand-name product Farxiga.

Medications with Dapagliflozin

The primary product that contains dapagliflozin in Hong Kong is Farxiga tablets. Farxiga is available in two strengths - 5 mg and 10 mg - and is supplied as a solid tablet taken by mouth. Generic dapagliflozin tablets, which contain the same active ingredient but are marketed under the chemical name, are also authorised and can be found in local pharmacies. All of these formulations are intended for oral use and are packaged in blister packs to protect the tablets from moisture.

What Dapagliflozin Is Used For

• Type 2 diabetes mellitus - Dapagliflozin helps lower blood-sugar levels when the body does not use insulin effectively.
• Heart failure with reduced ejection fraction - The medicine can improve symptoms and reduce the risk of hospital admission in patients whose heart’s pumping ability is weakened.
• Chronic kidney disease - By lowering blood-sugar and blood-pressure effects, dapagliflozin may slow the progression of kidney damage in certain adults.

These uses are approved by the Hong Kong Department of Health and are based on clinical studies that demonstrate benefit in the listed conditions.

How Dapagliflozin Works

Dapagliflozin blocks a protein in the kidneys called SGLT2, which normally re-absorbs glucose back into the bloodstream. When this protein is inhibited, more glucose is expelled in the urine, leading to lower blood-sugar levels. The increased loss of glucose also draws extra water out of the body, which can modestly lower blood pressure and reduce fluid buildup, why it can help with heart failure and kidney disease. Effects on blood-sugar are usually seen within a few days of starting the medicine.

Safety Information

Common Side Effects

• Mild genital or urinary-tract infections, often presenting as irritation or a change in urinary frequency.
• Increased urination and a feeling of thirst, which reflect the glucose-driven fluid loss.
• Slight dizziness or light-headedness, especially when standing up quickly.

These reactions are generally temporary and resolve without medical intervention.

Serious Reactions

• Ketoacidosis - a rare condition where the body produces high levels of acids called ketones. Symptoms may include nausea, vomiting, abdominal pain, rapid breathing, or a fruity-smelling breath.
• Severe allergic response - swelling of the face, lips, tongue, or throat, or difficulty breathing.
• Very low blood pressure - faintness, blurred vision, or loss of consciousness.

If any of these signs appear, seek emergency medical help immediately.

Who Should Be Cautious

• People who are pregnant, planning a pregnancy, or breastfeeding should avoid dapagliflozin unless specifically advised otherwise.
• Adults with markedly reduced kidney function may not be suitable candidates.
• Those who experience frequent low-blood-pressure episodes should discuss the risk with a health professional.

Interaction Awareness

• Diuretics (water pills) can amplify the fluid-loss effect, potentially leading to dehydration or low blood pressure.
• Insulin or other glucose-lowering medicines may increase the chance of low blood-sugar levels when combined with dapagliflozin.
• Alcohol intake can also raise the risk of dehydration and should be moderated.

For a full list of possible interactions, refer to the product’s official labeling or the dedicated page for the specific medication you are using.

What to Know Before Using

Store tablets in a dry place at room temperature, away from direct sunlight and moisture. The typical treatment course may be short-term for acute blood-sugar control or longer-term for heart-failure and kidney-disease management; the exact duration depends on the individual product and the condition being treated. Always follow the instructions printed on the medication’s packaging and keep this information handy for reference.

Key Terms

SGLT2 inhibitor: A type of drug that reduces glucose re-absorption in the kidneys, leading to increased urinary glucose excretion.

Ketoacidosis: A serious metabolic state where the body builds up excess acids called ketones, often triggered by very low insulin activity.

Ejection fraction: A measurement of how much blood the heart pumps out with each beat; reduced values indicate weaker heart function.

Information Disclaimer

This article offers general educational information about dapagliflozin as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing dapagliflozin may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.